GGrantIndex
Sort

16,179 grants matching malaria

An adjuvant for an RSV prefusion F vaccine that safely protects infants via maternal vaccination

$299,955
Mark Yondola · Calder Biosciences, Inc. · R43 · FY2019 · AI

PfAg, a multivalent peptide vaccine against malaria

$299,954
Yu-Min Chuang · L2 Diagnostics, Llc · R41 · FY2025 · AI

Conditional male lethal Anopheles stephensi line for the efficient manufacture of malaria vaccines

$299,951
Peter F. Billingsley · Sanaria, Inc. · R43 · FY2024 · AI

Simvastatin nanomedicine in ARDS and sepsis

$299,940
Shawn Kenny Roberts · Eunoia Bio Tech, Llc · R41 · FY2016 · GM

Rapid Development of a Highly Specific Dengue Diagnostic Test

$299,938
David I Watkins · Z-Quick, Llc · R41 · FY2019 · AI

CRISPR-based Tropical Infection Diagnostics

$299,937
Dmitry Zhukov · Chromologic, Llc · N43 · FY2023 · AI

Vaccination with purified, cryopreserved, infectious Plasmodium vivax sporozoites

$299,934
Stephen Lev Hoffman · Sanaria, Inc. · R43 · FY2013 · AI

PA21259, SBIR, Phase I, Improving T cell Responses in Vaccines: Prediction and Validation Using Existing Databases, Immunoinformatics and In Vitro Assays

$299,930
Mayara Grizotte-Lake · Epivax, Inc. · R43 · FY2022 · IP

Attenuated Malaria Sporozoite Vaccine

$299,916
Sanaria, Inc. · R43 · FY2003 · AI

Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria

$299,904
Vinayak S Joshi · Visionquest Biomedical, Llc · R43 · FY2014 · AI

Development of a Spirulina-based oral malaria vaccine

$299,904
Sean C Murphy · Lumen Bioscience, Inc. · R41 · FY2018 · AI

Administrative Core

$299,890
Diane V Havlir · University Of California, San Francisco · P01 · FY2014 · HD

Rapid development of a Zika-specific diagnostic test

$299,890
David I Watkins · Z-Quick, Llc · R41 · FY2018 · AI

Novel Ad5 Malaria Vaccine That Circumvents Pre-existing Ad5 Immunity

$299,889
Joseph T Bruder · Genvec, Inc. · R43 · FY2008 · AI

Development of Natural Product as Antimalarial Agent

$299,880
Shuren Zhu · Radix Pharmaceuticals, Inc. · R43 · FY2007 · AI

Pre-Clinical Development of Natural Product Analogues as Antimalarial Agents

$299,880
Shuren Zhu · Radix Pharmaceuticals, Inc. · R44 · FY2006 · AI

Delivery of a candidate AgTRIOVx malaria vaccine by thermostable microneedle patches

$299,878
Karen G. Anthony · L2 Diagnostics, Llc · R41 · FY2024 · AI

Molecular Epidemiology of Vivax Malaria in Ethiopia

$299,862
Guiyun Yan · University Of California-Irvine · R21 · FY2014 · AI

Delivery of a candidate AgTRIOVx malaria vaccine by thermostable microneedle patches

$299,862
Karen G. Anthony · L2 Diagnostics, Llc · R41 · FY2025 · AI

Intermodulation Peak Detection of Branched DNA for Compact-Apparatus Viral Load M

$299,852
Daniel James Laser · Wave 80 Biosciences, Inc. · R43 · FY2009 · AI

Monitoring System For Vector-Based Influenza Vaccine

$299,837
Matthew M. Ferris · Indevr, Inc. · R43 · FY2006 · AI

Spread-deficient HCMV-vectored vaccines

$299,835
Emily Elizabeth Marshall · Tomegavax, Inc. · R43 · FY2012 · AI

An adjuvant for an RSV prefusion F vaccine that safely protects infants via maternal vaccination

$299,787
Mark Yondola · Calder Biosciences, Inc. · R43 · FY2018 · AI

Development of monoclonal antibody-mediated interventions to combat malaria

$299,777
Jacqueline Miller · Cure Systems Llc · N43 · FY2022 · AI

Expression of Exogenous Genes in Vector Mosquitoes

$299,761
University Of California Irvine · R01 · FY2004 · AI